Literature DB >> 12353067

The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis.

Paolo Prandoni1, Anthonie W A Lensing, Enrico Bernardi, Sabina Villalta, Paola Bagatella, Antonio Girolami.   

Abstract

Diagnosis of recurrent deep-vein thrombosis (DVT) is difficult because of limitations in distinguishing acute from old thrombi. In the past, an ultrasound method for diagnosis of recurrent ipsilateral DVT was developed, which relies on repeated measurements of the diameters of the common femoral and popliteal veins. To assess the safety of withholding anticoagulation from patients with improved or stable compression vein diameters, 205 consecutive patients presenting with suspected recurrent ipsilateral DVT were evaluated. The vein diameter was measured under compression with the transducer and compared with earlier ultrasound results. Patients with stable or improved ultrasound findings had repeat ultrasound assessments after 2 (+/- 1) and 7 (+/- 1) days. Patients with repeatedly normal ultrasound results were followed-up for six months to determine the incidence of symptomatic recurrent venous thromboembolism. Of the 205 patients, 153 had stable or improved ultrasound findings. Repeat ultrasound assessment became abnormal in 3, and recurrence was confirmed by venography in all. A six months follow-up was done in the remaining 150 patients with repeatedly normal ultrasound tests and showed 2 (1.3%; 95% CI, 0.02 to 4.7%) confirmed non-fatal venous thromboembolic complications. The positive predictive value of a stable or improved ultrasound was 90% (95% CI, 77 to 97%). In conclusion, it is safe to withhold anticoagulant treatment from patients with suspected recurrent ipsilateral DVT in whom compression ultrasonography showed improved or stable vein diameters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353067

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  [Thromboembolism prophylaxis in old age].

Authors:  Gabriele Röhrig; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-04-05       Impact factor: 1.281

Review 3.  [Treatment of postoperative thrombosis].

Authors:  L-C Linke
Journal:  Orthopade       Date:  2009-09-06       Impact factor: 1.087

4.  A new prognostic strategy for adult patients with acute pulmonary embolism eligible for outpatient therapy.

Authors:  Federico Angriman; Fernando J Vazquez; Pierre Marie Roy; Gregoire Le Gal; Marc Carrier; Esteban Gandara
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

5.  Joint Guideline on Venous Thromboembolism - 2022.

Authors:  Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

6.  Diagnosis of deep vein thrombosis of the lower extremity: a systematic review and meta-analysis of test accuracy.

Authors:  Meha Bhatt; Cody Braun; Payal Patel; Parth Patel; Housne Begum; Wojtek Wiercioch; Jamie Varghese; David Wooldridge; Hani J Alturkmani; Merrill Thomas; Mariam Baig; Waled Bahaj; Rasha Khatib; Rohan Kehar; Rakesh Ponnapureddy; Anchal Sethi; Ahmad Mustafa; Robby Nieuwlaat; Wendy Lim; Shannon M Bates; Eddy Lang; Grégoire Le Gal; Marc Righini; Nedaa M Husainat; Mohamad A Kalot; Yazan Nayif Al Jabiri; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2020-04-14

7.  [Diagnostics in venous thrombosis and pulmonary embolism].

Authors:  S M Schellong
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

8.  Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program.

Authors:  Norikazu Yamada; Atsushi Hirayama; Hideaki Maeda; Satoru Sakagami; Hiroo Shikata; Martin H Prins; Anthonie Wa Lensing; Masaharu Kato; Junichi Onuma; Yuki Miyamoto; Kazuma Iekushi; Mariko Kajikawa
Journal:  Thromb J       Date:  2015-01-17

Review 9.  New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities.

Authors:  Paul P Dobesh; John Fanikos
Journal:  Drugs       Date:  2014-11       Impact factor: 9.546

10.  The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial.

Authors:  Arina J Ten Cate-Hoek; Annemieke C Bouman; Manuela A Joore; Martin Prins; Hugo Ten Cate
Journal:  BMJ Open       Date:  2014-09-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.